Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice

Long-acting nanoformulated antiretroviral therapy (nanoART) with improved pharmacokinetics, biodistribution and limited systemic toxicities will likely improve drug adherence and access to viral reservoirs. Atazanavir and ritonavir crystalline nanoART were formulated in a poloxamer-188 excipient by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2012-11, Vol.26 (17), p.2135-2144
Hauptverfasser: DASH, Prasanta K, GENDELMAN, Howard E, ROY, Upal, BALKUNDI, Shantanu, ALNOUTI, Yazen, MOSLEY, Rodney L, GELBARD, Harris A, MCMILLAN, Joellyn, GORANTLA, Santhi, POLUEKTOVA, Larisa Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!